Our Focus

 overview of nexus 1 orig


Considering the importance of the globally under served market for obesity treatments, there is a shortage of FDA approved drugs for overweight and obese patients. 

Currently available products will do one of three things: 

  1. Curb appetite.
  2. Induce satiety (feeling of fullness).
  3. Reduce absorption of fat in the intestines. 
The products in all three of these categories often have dangerous or unpleasant side effects.

​At Nexus, we are developing small molecule compounds that aim to stimulate weight loss and improve blood chemistry